Laura Hahn

ORCID: 0000-0003-3119-6053 · 3 papers in corpus
2026
·doi:10.1055/s-0046-1828188
2026
·doi:10.1055/s-0046-1828441
other 2024
Translational oncology ·doi:10.1016/j.tranon.2024.102116

OBJECTIVES: The chemokine CCL22 is recognized for recruiting immunosuppressive regulatory T-cells (Treg) that contribute to disease progression in various tumor entities helping them to evade the host immune response. Our study aims to iden…